Delphi Genetics Overview

  • Founded
  • 2001

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50M

Delphi Genetics General Information

Description

Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's tool is used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield, enabling researchers to significantly increase the stability of plasmid DNA in host strains, resulting in overall production yield and reproducibility improvement.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Rue A. de Saint-Exupéry, 5
  • 6041 Charleroi
  • Belgium

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delphi Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 25-Feb-2021 $50M 00.000 0000 Completed Generating Revenue
2. Debt - General 28-Jun-2016 00.000 00.000 Completed Generating Revenue
1. Later Stage VC 10-Mar-2015 $1.12M $1.12M Completed Generating Revenue
To view Delphi Genetics’s complete valuation and funding history, request access »

Delphi Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delphi Genetics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
50 North Ventures Venture Capital Minority 000 0000 000000 0
Invest4 DelphiG2 Other Minority 000 0000 000000 0
Michel Milinkovitch Angel (individual) Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
Université Libre de Bruxelles University Minority 000 0000 000000 0
To view Delphi Genetics’s complete investors history, request access »